Desogestrel (P medicine)

Pharmacy guide

Desogestrel is licensed as a pharmacy (P) medicine and available over the counter (OTC) as Lovima and Hana 75 microgram film-coated tablets. Pharmacists should be satisfied that the supply will be clinically suitable, and the product will be used appropriately.

This pharmacy guide covers what to consider before supplying desogestrel 75 microgram film-coated tablets OTC. 

There’s a handy flowchart to help you with decision-making on whether to supply or not. 

It also provides a summary of the product information. However, it doesn’t cover the full list of contraindications or risk information.

Further details can be found in the products individual Summary of Product Characteristics (SPC).

First Published: 12 November 2020
Updated: 26 October 2021

Sections on this page

  • Desogestrel
  • Summary of product information
  • Education for pharmacy teams
  • Confidence in consultation skills
  • Decision-making process and flowchart for supply
  • Repeat supply requests
  • Supply to the person’s representative
  • Counselling
  • Quantity to supply
  • Record keeping
  • Contraception options and sexual health
  • Vulnerable adults and children - safeguarding
  • Moral beliefs
  • Further information

Become a Royal Pharmaceutical Society member to view this content.


A day you'll remember: #RPSConf22


On Friday 11 November, we'll change how you think about pharmacy, how you work with colleagues, and how you see yourself and your future!


Join us and discover how much pharmacy is changing. It’s a day for you to listen, to learn, and to discuss - as well as to enjoy meeting all your fellow professionals.

Get inspired with us on Friday, 11 November, and discover the future of pharmacy.